wire - news in brief

To diagnose lung cancer and determine the optimal treatment strategy, physicians typically rely on tissue examination.

Greater understanding of how depression progresses thanks to brain scan. Depression affects millions of people worldwide, but much is still unknown about this illness and treatments don't always work.

Preventing hearing loss requires delivering medication to the inner ear. Currently, this is done through surgery or an imprecise drop method.

FORESIGHT consortium stimulates molecular imaging in the development of new immunotherapy drugs and the matching of existing drugs with patients.

TU/e's Precision Medicine group develops nature-inspired nanotechnology to use genetic drugs as immunotherapy.

AI can help diagnose and treat pancreatic cancer. Two young TU/e-researchers talk about their project.

Sander van den Borne defends his EngD thesis on September 20th at the school of medical physics and engineering Eindhoven, which is part of the department of Biomedical Engineering.

Cancer cells are known to take advantage of a mechanism called cell competition, a quality control system that ensures that our tissues are composed of healthy cells.

The Centre for Human Drug Research (CHDR) is about to open a new location in Twente. At this location, the Leiden-based drug research institute will work closely with the regional hospital Medisch Spectrum Twente (MST) and University of Twente's Technical Medical Centre (TechMed Centre).

Utrecht University has appointed Helga Gardarsdottir as Professor of Real World Data for Decision Making on Medicines.

Two Radboud researchers are set to receive a Consolidator Grant from the European Research Council (ERC).

In two publications in the renowned scientific journal Nature Reviews Drug Discovery, Anneliene Jonker (TechMed Centre) highlights the importance of healthcare for rare diseases, and the innovation needed in that.

By starting a company, PhD candidate Lucas Czentner has taken an important step towards realizing clinical trials of a new cancer treatment.

By starting a company, PhD candidate Lucas Czentner makes great strides towards realising clinical trials of a new cancer treatment.

The origins of self-assembly, data visualization, increasing access to affordable medicines, and ultrasound imaging are the topics to receive the NWO funding.

ReumaNederland is providing €500,000 for long-term follow-up research into a vaccine against inflammatory rheumatism.

  Many people with chronic inflammatory bowel diseases such as Crohn's disease or ulcerative colitis continue to experience persistent abdominal pain.

There is a saying in Dutch: "Met het mes op tafel" which translates to "With the knife on the table".

Wendy Olsder defended her thesis at the department of Industrial Engineering and Innovation Sciences on February 9th, 2023.

On January 25, the NUTRIM Clinical Research Unit (CRU) for patient-related research on nutrition and metabolism was officially opened at Maastricht UMC+.

In part two of our year-end series, we talk with Roy van der Meel about his quest to find clever ways to deliver drugs into the body.

Heart-on-a-Chip devices are microfluidic devices that enable the replication of a human heart at the microscale.

After diagnosis and treatment of breast cancer, many women suffer from cancer-related fatigue. Twenty percent of the patients are still severely fatigued after ten years.

Survivors of colon cancer often have symptoms associated with the cancer or treatment for years after treatment, such as fatigue and tingling in fingers and feet. This has a great impact on the perceived quality of life. Whereas current lifestyle advice is mainly aimed at prevention of (colon) cancer, Marlou-Floor Kenkhuis studied in her PhD the relationship between lifestyle with quality of life and fatigue in colon cancer survivors.

QurieGen is a new spin-off of Radboud University that supports pharmaceutical companies in the early identification of successful drug molecules.